Fate Therapeutics Inc (FATE)

Dec 14, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Consensus Rating of “Hold” by Analysts - Defense World

Dec 14, 2025

Dec 13, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Dec 13, 2025

Dec 09, 2025

Healthy Upside Potential: Fate Therapeutics Inc (FATE) - setenews.com

Dec 09, 2025

Dec 09, 2025

Fate Therapeutics Inc Stock Analysis and ForecastMarket Profile Overview & Fast Profit Portfolio Plans - earlytimes.in

Dec 09, 2025

Dec 08, 2025

Fate Therapeutics reports positive lupus treatment data at ASH meeting - Investing.com

Dec 08, 2025

Dec 08, 2025

Fate Therapeutics reports positive lupus treatment data at ASH meeting By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Fate Therapeutics Reports Positive Clinical Updates for FT819 in Systemic Lupus Erythematosus and Introduces Next-Generation CAR T-Cell Programs at ASH Annual Meeting - Quiver Quantitative

Dec 08, 2025

Dec 08, 2025

Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs - The Manila Times

Dec 08, 2025

Dec 08, 2025

Fate Therapeutics, Inc. Presents Updated Phase 1 Clinical Data of FT819 Off-The-Shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-The-Shelf Car T-Shelf CAR T-Cell Programs - marketscreener.com

Dec 08, 2025

Dec 06, 2025

Fate Therapeutics (NASDAQ:FATE) Stock Passes Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Dec 06, 2025

Dec 04, 2025

How Fate Therapeutics Inc. stock valuations compare to rivalsWeekly Profit Recap & Reliable Volume Spike Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Why Fate Therapeutics Inc. stock remains on buy listsWatch List & Safe Entry Point Identification - Newser

Dec 03, 2025

Dec 03, 2025

Will Fate Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Verified Swing Trading Watchlists - Newser

Dec 03, 2025

Dec 02, 2025

Published on: 2025-12-02 03:44:47 - Newser

Dec 02, 2025

Dec 01, 2025

Fate Therapeutics (FATE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Dec 01, 2025

Check Out Fate Therapeutics Inc (FATE)’s Trade Data Rather Than the Analysts’ Views - setenews.com

Dec 01, 2025

Nov 28, 2025

Fate Therapeutics (NASDAQ:FATE) Stock Price Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Nov 28, 2025

Nov 25, 2025

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 - Quiver Quantitative

Nov 25, 2025

Nov 25, 2025

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire

Nov 25, 2025

Nov 25, 2025

Here's Why We're A Bit Worried About Fate Therapeutics' (NASDAQ:FATE) Cash Burn Situation - simplywall.st

Nov 25, 2025

Nov 21, 2025

Cantor Fitzgerald Issues Positive Outlook for FATE Earnings - MarketBeat

Nov 21, 2025

Nov 19, 2025

Multi factor analysis applied to Fate Therapeutics Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Tools to monitor Fate Therapeutics Inc. recovery probabilityBuy Signal & Growth Oriented Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Automated trading signals detected on Fate Therapeutics Inc.Short Setup & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Fate Therapeutics Inc. stock outperform Nasdaq indexQuarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025

Nov 18, 2025

Is Fate Therapeutics Inc. stock undervalued vs historical averagesEarnings Trend Report & Capital Efficient Trade Techniques - newser.com

Nov 18, 2025

Nov 18, 2025

Exit strategy if you’re trapped in Fate Therapeutics Inc.Portfolio Return Summary & Daily Entry Point Trade Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by Brokerages - MarketBeat

Nov 18, 2025

Nov 18, 2025

Will Fate Therapeutics Inc. see short term momentumEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com

Nov 18, 2025

Nov 17, 2025

Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts - TipRanks

Nov 17, 2025

Nov 16, 2025

How sentiment analysis helps forecast Fate Therapeutics Inc.2025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com

Nov 16, 2025

Nov 16, 2025

Published on: 2025-11-16 18:05:52 - newser.com

Nov 16, 2025

Nov 16, 2025

Will Fate Therapeutics Inc. stock recover faster than market2025 EndofYear Setup & Safe Entry Zone Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Fate Therapeutics (FATE) Receives a Hold from Bank of America Securities - The Globe and Mail

Nov 16, 2025

Nov 16, 2025

Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks - MSN

Nov 16, 2025

Nov 15, 2025

Why Fate Therapeutics Inc. stock remains a top recommendationPortfolio Gains Report & Verified Stock Trade Ideas - newser.com

Nov 15, 2025

Nov 15, 2025

How resilient is Fate Therapeutics Inc. stock in market downturns2025 AllTime Highs & Weekly High Return Opportunities - newser.com

Nov 15, 2025

Nov 15, 2025

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates - MSN

Nov 15, 2025

Nov 14, 2025

Fate Therapeutics (NASDAQ:FATE) Announces Quarterly Earnings Results - MarketBeat

Nov 14, 2025